Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2624 (LINC02624) is a member of the lincRNA family, a subgroup of long non-coding RNAs transcribed from intergenic regions in the genome that do not overlap protein-coding genes[1][3][5][7]. Like other lincRNAs, LINC02624 is presumed to play a role in gene regulatory networks, potentially affecting chromatin structure, transcription, or post-transcriptional regulation, though no published experimental data specifically define its function, associated biological pathways, or roles in health or disease[5][7]. There is currently no evidence suggesting it is a protein-coding gene, therapeutic target, or established disease biomarker, and it is not associated with known drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2624 (LINC02624).